Quattro Financial Advisors LLC Astrazeneca PLC Transaction History
Quattro Financial Advisors LLC
- $3.72 Million
- Q3 2024
A detailed history of Quattro Financial Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Quattro Financial Advisors LLC holds 11,922 shares of AZN stock, worth $800,919. This represents 24.98% of its overall portfolio holdings.
Number of Shares
11,922
Previous 5,000
138.44%
Holding current value
$800,919
Previous $389,000
138.56%
% of portfolio
24.98%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.23 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.82 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...